BioNTech said that BNT327 has the "potential to replace current checkpoint inhibitor standard of care treatments for solid ...
M uch to the chagrin of investors looking to get rich quickly with a biopharma investment, the drug development cycle is, by ...
Enrollment on track in Phase 2 portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in patients with TP53 Y220C and KRAS ...
Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous ...
Vaccinex has global commercial and development rights to pepinemab and is the sponsor of the KEYNOTE-B84 study which is being performed in collaboration with Merck Sharp & Dohme Corp, a subsidiary of ...
Good afternoon, everyone. Thank you for standing by. Welcome to CytomX Therapeutics third quarter, 2024 Financial results call. Please be advised that today's call is being recorded. I would now like ...
With the end of 2024 approaching, what could be more natural than to figure out the top stocks for the rest of the year?
The structure of a small molecule can also be shown as a three-dimensional ball-and-stick model. These models show how the atoms and bonds are arranged in space. The diagram shows a ball-and-stick ...